Interruptions in treatment among adults on anti-retroviral therapy before and after test-and-treat policy in Tanzania.

<h4>Introduction</h4>The World Health Organization recommended the initiation of antiretroviral therapy (ART) for people living with HIV (PLHIV) regardless of CD4 cell counts. Tanzania adopted this recommendation known as test-and-treat policy in 2016. However, programmatic implementatio...

Full description

Bibliographic Details
Main Authors: Redempta J Mbatia, Expeditho L Mtisi, Abbas Ismail, Christopher V Henjewele, Sisty J Moshi, Alexander K Christopher, Noela W Nsanzugwanko, Appolinary G Bukuku, Rehema A Msimbe, Agnes R Kirato, Francis S Nyabukene, Eunice J Mmari, Anath A Rwebembera, Benedicta N Masanja, Alexander Kailembo, Eva J Matiko
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0292740&type=printable
_version_ 1797315885144211456
author Redempta J Mbatia
Expeditho L Mtisi
Abbas Ismail
Christopher V Henjewele
Sisty J Moshi
Alexander K Christopher
Noela W Nsanzugwanko
Appolinary G Bukuku
Rehema A Msimbe
Agnes R Kirato
Francis S Nyabukene
Eunice J Mmari
Anath A Rwebembera
Benedicta N Masanja
Alexander Kailembo
Eva J Matiko
author_facet Redempta J Mbatia
Expeditho L Mtisi
Abbas Ismail
Christopher V Henjewele
Sisty J Moshi
Alexander K Christopher
Noela W Nsanzugwanko
Appolinary G Bukuku
Rehema A Msimbe
Agnes R Kirato
Francis S Nyabukene
Eunice J Mmari
Anath A Rwebembera
Benedicta N Masanja
Alexander Kailembo
Eva J Matiko
author_sort Redempta J Mbatia
collection DOAJ
description <h4>Introduction</h4>The World Health Organization recommended the initiation of antiretroviral therapy (ART) for people living with HIV (PLHIV) regardless of CD4 cell counts. Tanzania adopted this recommendation known as test-and-treat policy in 2016. However, programmatic implementation of this policy has not been assessed since its initiation. The objective of the study was to assess the impact of this policy in Tanzania.<h4>Methods</h4>This was a cross-sectional study among PLHIV aged 15 years and older using routinely collected program data. The dependent variable was interruption in treatment (IIT), defined as no clinical contact for at least 90 days after the last clinical appointment. The main independent variable was test-and-treat policy status which categorized PLHIV into the before and after groups. Co-variates were age, sex, facility type, clinical stage, CD4 count, ART duration, and body mass index. The associations were assessed using the generalized estimating equation with inverse probability weighting.<h4>Results</h4>The study involved 33,979 PLHIV-14,442 (42.5%) and 19,537 (57.5%) were in the before and after the policy groups, respectively. Among those who experienced IIT, 4,219 (29%) and 7,322 (38%) were in the before and after the policy groups respectively. Multivariable analysis showed PLHIV after the policy was instated had twice [AOR 2.03; 95%CI 1.74-2.38] the odds of experiencing IIT than those before the policy was adopted. Additionally, higher odds of experiencing IIT were observed among younger adults, males, and those with advanced HIV disease.<h4>Conclusion</h4>Demographic and clinical status variables were associated with IIT, as well as the test-and-treat policy. To achieve epidemic control, programmatic adjustments on continuity of treatment may are needed to complement the programmatic implementation of the policy.
first_indexed 2024-03-08T03:10:20Z
format Article
id doaj.art-e638663413de45e59bd76bc86a9fafb8
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-03-08T03:10:20Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e638663413de45e59bd76bc86a9fafb82024-02-13T05:34:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-011811e029274010.1371/journal.pone.0292740Interruptions in treatment among adults on anti-retroviral therapy before and after test-and-treat policy in Tanzania.Redempta J MbatiaExpeditho L MtisiAbbas IsmailChristopher V HenjeweleSisty J MoshiAlexander K ChristopherNoela W NsanzugwankoAppolinary G BukukuRehema A MsimbeAgnes R KiratoFrancis S NyabukeneEunice J MmariAnath A RwebemberaBenedicta N MasanjaAlexander KailemboEva J Matiko<h4>Introduction</h4>The World Health Organization recommended the initiation of antiretroviral therapy (ART) for people living with HIV (PLHIV) regardless of CD4 cell counts. Tanzania adopted this recommendation known as test-and-treat policy in 2016. However, programmatic implementation of this policy has not been assessed since its initiation. The objective of the study was to assess the impact of this policy in Tanzania.<h4>Methods</h4>This was a cross-sectional study among PLHIV aged 15 years and older using routinely collected program data. The dependent variable was interruption in treatment (IIT), defined as no clinical contact for at least 90 days after the last clinical appointment. The main independent variable was test-and-treat policy status which categorized PLHIV into the before and after groups. Co-variates were age, sex, facility type, clinical stage, CD4 count, ART duration, and body mass index. The associations were assessed using the generalized estimating equation with inverse probability weighting.<h4>Results</h4>The study involved 33,979 PLHIV-14,442 (42.5%) and 19,537 (57.5%) were in the before and after the policy groups, respectively. Among those who experienced IIT, 4,219 (29%) and 7,322 (38%) were in the before and after the policy groups respectively. Multivariable analysis showed PLHIV after the policy was instated had twice [AOR 2.03; 95%CI 1.74-2.38] the odds of experiencing IIT than those before the policy was adopted. Additionally, higher odds of experiencing IIT were observed among younger adults, males, and those with advanced HIV disease.<h4>Conclusion</h4>Demographic and clinical status variables were associated with IIT, as well as the test-and-treat policy. To achieve epidemic control, programmatic adjustments on continuity of treatment may are needed to complement the programmatic implementation of the policy.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0292740&type=printable
spellingShingle Redempta J Mbatia
Expeditho L Mtisi
Abbas Ismail
Christopher V Henjewele
Sisty J Moshi
Alexander K Christopher
Noela W Nsanzugwanko
Appolinary G Bukuku
Rehema A Msimbe
Agnes R Kirato
Francis S Nyabukene
Eunice J Mmari
Anath A Rwebembera
Benedicta N Masanja
Alexander Kailembo
Eva J Matiko
Interruptions in treatment among adults on anti-retroviral therapy before and after test-and-treat policy in Tanzania.
PLoS ONE
title Interruptions in treatment among adults on anti-retroviral therapy before and after test-and-treat policy in Tanzania.
title_full Interruptions in treatment among adults on anti-retroviral therapy before and after test-and-treat policy in Tanzania.
title_fullStr Interruptions in treatment among adults on anti-retroviral therapy before and after test-and-treat policy in Tanzania.
title_full_unstemmed Interruptions in treatment among adults on anti-retroviral therapy before and after test-and-treat policy in Tanzania.
title_short Interruptions in treatment among adults on anti-retroviral therapy before and after test-and-treat policy in Tanzania.
title_sort interruptions in treatment among adults on anti retroviral therapy before and after test and treat policy in tanzania
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0292740&type=printable
work_keys_str_mv AT redemptajmbatia interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT expeditholmtisi interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT abbasismail interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT christophervhenjewele interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT sistyjmoshi interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT alexanderkchristopher interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT noelawnsanzugwanko interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT appolinarygbukuku interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT rehemaamsimbe interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT agnesrkirato interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT francissnyabukene interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT eunicejmmari interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT anatharwebembera interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT benedictanmasanja interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT alexanderkailembo interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania
AT evajmatiko interruptionsintreatmentamongadultsonantiretroviraltherapybeforeandaftertestandtreatpolicyintanzania